As of 2024-07-27, the Intrinsic Value of Aptose Biosciences Inc (APS.TO) is
-19.86 CAD. This APS.TO valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.79 CAD, the upside of Aptose Biosciences Inc is
-2,613.36%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-19.86 CAD
Intrinsic Value
APS.TO Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-19.86 - -19.86 |
-19.86 |
-2,613.36% |
| P/E |
(6.19) - (7.86) |
(7.15) |
-1004.8% |
| DDM - Stable |
(19.34) - (68.31) |
(43.82) |
-5647.3% |
| DDM - Multi |
(16.64) - (50.34) |
(25.55) |
-3334.3% |
APS.TO Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
12.88 |
| Beta |
-0.49 |
| Outstanding shares (mil) |
16.31 |
| Enterprise Value (mil) |
2.80 |
| Market risk premium |
5.10% |
| Cost of Equity |
13.73% |
| Cost of Debt |
5.00% |
| WACC |
8.71% |